A detailed history of Rothschild Investment LLC transactions in Compugen LTD stock. As of the latest transaction made, Rothschild Investment LLC holds 203,900 shares of CGEN stock, worth $334,396. This represents 0.02% of its overall portfolio holdings.

Number of Shares
203,900
Previous 221,900 8.11%
Holding current value
$334,396
Previous $380 Million 2.93%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$1.56 - $2.1 $28,080 - $37,800
-18,000 Reduced 8.11%
203,900 $369 Million
Q2 2024

Jul 30, 2024

BUY
$1.68 - $2.52 $372,792 - $559,188
221,900 New
221,900 $380 Million
Q1 2024

Jul 31, 2024

SELL
$1.75 - $2.95 $15,137 - $25,517
-8,650 Reduced 3.55%
235,000 $606 Million
Q4 2023

Jul 31, 2024

BUY
$0.53 - $2.0 $11,527 - $43,500
21,750 Added 9.8%
243,650 $479 Million

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.